ID   IP3KA_HUMAN             Reviewed;         461 AA.
AC   P23677; Q8TAN3;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 1.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Inositol-trisphosphate 3-kinase A;
DE            EC=2.7.1.127;
DE   AltName: Full=Inositol 1,4,5-trisphosphate 3-kinase A;
DE            Short=IP3 3-kinase A;
DE            Short=IP3K A;
DE            Short=InsP 3-kinase A;
GN   Name=ITPKA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=1847047; DOI=10.1016/0006-291X(91)91449-M;
RA   Takazawa K., Perret J., Dumont J.E., Erneux C.;
RT   "Molecular cloning and expression of a human brain inositol 1,4,5-
RT   trisphosphate 3-kinase.";
RL   Biochem. Biophys. Res. Commun. 174:529-535(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2175886; DOI=10.1093/nar/18.23.7141;
RA   Takazawa K., Perret J., Dumont J.E., Erneux C.;
RT   "Human brain inositol 1,4,5-trisphosphate 3-kinase cDNA sequence.";
RL   Nucleic Acids Res. 18:7141-7141(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 197-461 IN COMPLEX WITH
RP   SUBSTRATE AND ADP.
RX   PubMed=15350214; DOI=10.1016/j.molcel.2004.08.004;
RA   Gonzalez B., Schell M.J., Letcher A.J., Veprintsev D.B., Irvine R.F.,
RA   Williams R.L.;
RT   "Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate
RT   binding reveals why it is not a phosphoinositide 3-kinase.";
RL   Mol. Cell 15:689-701(2004).
CC   -!- CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1,4,5-trisphosphate =
CC       ADP + 1D-myo-inositol 1,3,4,5-tetrakisphosphate.
CC   -!- ENZYME REGULATION: IP3K is activated by calmodulin.
CC   -!- SIMILARITY: Belongs to the inositol phosphokinase (IPK) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X54938; CAA38700.1; -; mRNA.
DR   EMBL; BC026331; AAH26331.1; -; mRNA.
DR   CCDS; CCDS10076.1; -.
DR   PIR; JN0129; JN0129.
DR   RefSeq; NP_002211.1; NM_002220.2.
DR   UniGene; Hs.2722; -.
DR   PDB; 1W2C; X-ray; 1.95 A; A/B=197-461.
DR   PDB; 1W2D; X-ray; 1.94 A; A/B=197-461.
DR   PDB; 1W2F; X-ray; 1.80 A; A/B=188-461.
DR   PDB; 4UPU; X-ray; 2.34 A; B=158-183.
DR   PDBsum; 1W2C; -.
DR   PDBsum; 1W2D; -.
DR   PDBsum; 1W2F; -.
DR   PDBsum; 4UPU; -.
DR   ProteinModelPortal; P23677; -.
DR   SMR; P23677; -.
DR   BioGrid; 109911; 2.
DR   IntAct; P23677; 1.
DR   STRING; 9606.ENSP00000260386; -.
DR   BindingDB; P23677; -.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   iPTMnet; P23677; -.
DR   PhosphoSitePlus; P23677; -.
DR   BioMuta; ITPKA; -.
DR   DMDM; 124807; -.
DR   EPD; P23677; -.
DR   MaxQB; P23677; -.
DR   PaxDb; P23677; -.
DR   PeptideAtlas; P23677; -.
DR   PRIDE; P23677; -.
DR   DNASU; 3706; -.
DR   Ensembl; ENST00000260386; ENSP00000260386; ENSG00000137825.
DR   GeneID; 3706; -.
DR   KEGG; hsa:3706; -.
DR   UCSC; uc001znz.4; human.
DR   CTD; 3706; -.
DR   DisGeNET; 3706; -.
DR   GeneCards; ITPKA; -.
DR   HGNC; HGNC:6178; ITPKA.
DR   HPA; HPA040454; -.
DR   MIM; 147521; gene.
DR   neXtProt; NX_P23677; -.
DR   OpenTargets; ENSG00000137825; -.
DR   PharmGKB; PA29975; -.
DR   eggNOG; KOG1621; Eukaryota.
DR   eggNOG; ENOG410Y8AC; LUCA.
DR   GeneTree; ENSGT00390000017438; -.
DR   HOGENOM; HOG000231765; -.
DR   HOVERGEN; HBG052138; -.
DR   InParanoid; P23677; -.
DR   KO; K00911; -.
DR   OMA; WLPAVGS; -.
DR   OrthoDB; EOG091G03J3; -.
DR   PhylomeDB; P23677; -.
DR   TreeFam; TF318394; -.
DR   BioCyc; MetaCyc:HS06405-MONOMER; -.
DR   BRENDA; 2.7.1.127; 2681.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   SIGNOR; P23677; -.
DR   ChiTaRS; ITPKA; human.
DR   EvolutionaryTrace; P23677; -.
DR   GeneWiki; ITPKA; -.
DR   GenomeRNAi; 3706; -.
DR   PRO; PR:P23677; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000137825; -.
DR   CleanEx; HS_ITPKA; -.
DR   ExpressionAtlas; P23677; baseline and differential.
DR   Genevisible; P23677; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:Ensembl.
DR   GO; GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0048365; F:Rac GTPase binding; IEA:Ensembl.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0097062; P:dendritic spine maintenance; IEA:Ensembl.
DR   GO; GO:0006020; P:inositol metabolic process; IEA:Ensembl.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IEA:Ensembl.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR005522; IPK.
DR   PANTHER; PTHR12400; PTHR12400; 1.
DR   Pfam; PF03770; IPK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Complete proteome;
KW   Kinase; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   CHAIN         1    461       Inositol-trisphosphate 3-kinase A.
FT                                /FTId=PRO_0000066865.
FT   NP_BIND     249    251       ATP. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   REGION      287    295       Calmodulin-binding. {ECO:0000250}.
FT   REGION      312    319       Substrate binding.
FT                                {ECO:0000269|PubMed:15350214}.
FT   BINDING     197    197       ATP. {ECO:0000244|PDB:1W2D,
FT                                ECO:0000269|PubMed:15350214}.
FT   BINDING     209    209       ATP. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   BINDING     262    262       ATP. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   BINDING     264    264       Substrate. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   BINDING     285    285       Substrate. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   BINDING     336    336       ATP. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   BINDING     416    416       ATP. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   BINDING     419    419       Substrate. {ECO:0000244|PDB:1W2C,
FT                                ECO:0000269|PubMed:15350214}.
FT   MOD_RES      35     35       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q8R071}.
FT   MOD_RES      55     55       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q8R071}.
FT   MOD_RES      62     62       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q8R071}.
FT   MOD_RES     137    137       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8R071}.
FT   MOD_RES     197    197       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT     71     71       P -> Q (in Ref. 3; AAH26331).
FT                                {ECO:0000305}.
FT   HELIX       166    174       {ECO:0000244|PDB:4UPU}.
FT   TURN        177    179       {ECO:0000244|PDB:4UPU}.
FT   HELIX       188    191       {ECO:0000244|PDB:1W2F}.
FT   STRAND      198    200       {ECO:0000244|PDB:1W2D}.
FT   STRAND      206    210       {ECO:0000244|PDB:1W2F}.
FT   HELIX       213    223       {ECO:0000244|PDB:1W2F}.
FT   HELIX       226    230       {ECO:0000244|PDB:1W2F}.
FT   STRAND      234    240       {ECO:0000244|PDB:1W2F}.
FT   STRAND      243    249       {ECO:0000244|PDB:1W2F}.
FT   TURN        251    254       {ECO:0000244|PDB:1W2F}.
FT   STRAND      259    267       {ECO:0000244|PDB:1W2F}.
FT   HELIX       272    280       {ECO:0000244|PDB:1W2F}.
FT   HELIX       286    295       {ECO:0000244|PDB:1W2F}.
FT   HELIX       302    307       {ECO:0000244|PDB:1W2F}.
FT   HELIX       312    322       {ECO:0000244|PDB:1W2F}.
FT   HELIX       325    328       {ECO:0000244|PDB:1W2F}.
FT   STRAND      329    336       {ECO:0000244|PDB:1W2F}.
FT   STRAND      338    340       {ECO:0000244|PDB:1W2D}.
FT   HELIX       352    363       {ECO:0000244|PDB:1W2F}.
FT   HELIX       367    384       {ECO:0000244|PDB:1W2F}.
FT   HELIX       388    391       {ECO:0000244|PDB:1W2F}.
FT   STRAND      393    397       {ECO:0000244|PDB:1W2F}.
FT   STRAND      399    404       {ECO:0000244|PDB:1W2F}.
FT   STRAND      410    415       {ECO:0000244|PDB:1W2F}.
FT   STRAND      419    422       {ECO:0000244|PDB:1W2F}.
FT   STRAND      431    433       {ECO:0000244|PDB:1W2D}.
FT   HELIX       444    459       {ECO:0000244|PDB:1W2F}.
SQ   SEQUENCE   461 AA;  51009 MW;  18CA214A091F5B19 CRC64;
     MTLPGGPTGM ARPGGARPCS PGLERAPRRS VGELRLLFEA RCAAVAAAAA AGEPRARGAK
     RRGGQVPNGL PRAPPAPVIP QLTVTAEEPD VPPTSPGPPE RERDCLPAAG SSHLQQPRRL
     STSSVSSTGS SSLLEDSEDD LLSDSESRSR GNVQLEAGED VGQKNHWQKI RTMVNLPVIS
     PFKKRYAWVQ LAGHTGSFKA AGTSGLILKR CSEPERYCLA RLMADALRGC VPAFHGVVER
     DGESYLQLQD LLDGFDGPCV LDCKMGVRTY LEEELTKARE RPKLRKDMYK KMLAVDPEAP
     TEEEHAQRAV TKPRYMQWRE GISSSTTLGF RIEGIKKADG SCSTDFKTTR SREQVLRVFE
     EFVQGDEEVL RRYLNRLQQI RDTLEVSEFF RRHEVIGSSL LFVHDHCHRA GVWLIDFGKT
     TPLPDGQILD HRRPWEEGNR EDGYLLGLDN LIGILASLAE R
//
